MEDIVATION INC's ticker is MDVN and the CUSIP is 58501N101. A total of 56 filers reported holding MEDIVATION INC in Q3 2016. The put-call ratio across all filers is 2.08 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2016 | $6,087,000 | +275.5% | 100,939 | +186.3% | 0.01% | +250.0% |
| Q1 2016 | $1,621,000 | -12.1% | 35,262 | -7.5% | 0.00% | 0.0% |
| Q4 2015 | $1,844,000 | +22.9% | 38,138 | +8.0% | 0.00% | 0.0% |
| Q3 2015 | $1,500,000 | -23.3% | 35,302 | +106.2% | 0.00% | 0.0% |
| Q2 2015 | $1,955,000 | +3.6% | 17,118 | +17.1% | 0.00% | 0.0% |
| Q1 2015 | $1,887,000 | +20.3% | 14,614 | -7.2% | 0.00% | 0.0% |
| Q4 2014 | $1,568,000 | -78.1% | 15,745 | -78.3% | 0.00% | -75.0% |
| Q3 2014 | $7,160,000 | +937.7% | 72,415 | +709.1% | 0.01% | +700.0% |
| Q2 2014 | $690,000 | +19.8% | 8,950 | 0.0% | 0.00% | 0.0% |
| Q1 2014 | $576,000 | +4.3% | 8,950 | +3.4% | 0.00% | 0.0% |
| Q4 2013 | $552,000 | -70.9% | 8,655 | -72.7% | 0.00% | -66.7% |
| Q3 2013 | $1,898,000 | +39.5% | 31,659 | +14.5% | 0.00% | +50.0% |
| Q2 2013 | $1,361,000 | – | 27,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 2,504,101 | $123,202,000 | 84.26% |
| BB BIOTECH AG | 1,449,706 | $71,326,000 | 5.14% |
| SECTORAL ASSET MANAGEMENT INC | 2,717,173 | $133,685,000 | 3.95% |
| PFM Health Sciences, LP | 2,417,306 | $118,931,000 | 2.47% |
| Bain Capital Public Equity Management, LLC | 2,127,075 | $104,652,000 | 2.45% |
| Partner Investment Management, L.P. | 205,257 | $10,099,000 | 2.28% |
| TRAXIS PARTNERS LP | 60,000 | $2,952,000 | 2.28% |
| HealthCor Management, L.P. | 650,000 | $31,980,000 | 1.93% |
| Loeb Offshore Management LP | 73,825 | $3,632,000 | 1.86% |
| QVT Financial LP | 547,628 | $26,943,000 | 1.81% |